Fig. 1From: Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational studyPatient selectionAsthma exacerbations were defined as outpatient or emergency department visits with a diagnosis of asthma and at least one dispensing of systemic corticosteroids ± 5 days after the encounter or exacerbations resulting in hospitalization/inpatient hospital admission with a diagnosis of asthma as a primary diagnosisICES, Institute for Clinical and Evaluative Sciences; PSP, patient support programBack to article page